Reported Q: Q1 2025 Rev YoY: +67.3% EPS YoY: +521.1% Move: +0.03%
Centrus Energy Corp
LEU
$193.31 0.03%
Exchange NYSE Sector Energy Industry Uranium
Q1 2025
Published: May 8, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for LEU

Reported

Report Date

May 8, 2025

Quarter Q1 2025

Revenue

73.10M

YoY: +67.3%

EPS

1.60

YoY: +521.1%

Market Move

+0.03%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $73.10M up 67.3% year-over-year
  • EPS of $1.60 increased by 521.1% from previous year
  • Gross margin of 45.0%
  • Net income of 27.20M
  • "We are the only company currently enriching uranium with US-owned, US origin enrichment technology backed by an American supply chain empowered by American workers." - Amir Vexler
LEU
Company LEU

Swipe to view all report sections

Executive Summary

Centrus Energy Corp delivered a robust QQ1 2025, underscored by a higher than year-ago top line, solid gross margins, and meaningful cash generation, anchored by the LEU segmentโ€™s SWU sales and an improving balance sheet. Revenue of $73.1 million rose ~67% year over year, driven by higher volume and higher average SWU prices, while gross profit expanded to $32.9 million and operating income reached $20.5 million, delivering a quarterly net income of $27.2 million and EPS of $1.60. The quarter benefited from the timing of a fourth-quarter Russian supply disruption that shifted shipments into Q1 2025 and from a nonrecurring lower-margin contract in Q1 2024, which amplified YoY comparables but does not alter the underlying momentum in the LEU business.

Strategically, Centrus is advancing a four-pronged plan to bolster long-term capacity and U.S. nuclear fuel security: (1) balance-sheet strengthening via debt redemption and convertible financing; (2) a $60 million domestic centrifuge supply-chain investment to restart and expand Oak Ridge manufacturing; (3) continuous HALEU production at Piketon with DOE delivery commitments and a cumulative ~670 kg HALEU delivered to date; and (4) ongoing public-private advocacy to secure U.S. funding for domestic enrichment capacity. The company ended QQ1 with a strong cash position of $685.7 million (including $32.7 million of restricted cash) and a net debt position of approximately negative $195 million, reflecting substantial liquidity to fund near-term obligations and select investments.

Near-term catalysts include potential DOE awards from the $3.4 billion nuclear-fuel package, progress on HALEU deployment timelines (the company maintains that its 42-month rollout target after funding remains intact), and continued advancement of Piketon and Oak Ridge initiatives. Management stresses the inherent volatility of quarterly results given multiyear LEU contracts and shipment timing, but asserts the annual picture remains favorable as domestic enrichment demand grows and U.S. supply chains diversify. Investors should monitor DOE funding decisions, progress on the HALEU cascade, and the evolution of contingent LEU sales tied to Piketon capacity expansion.

Key Performance Indicators

Revenue
Increasing
73.10M
QoQ: -51.78% | YoY: 67.28%
Gross Profit
Increasing
32.90M
45.01% margin
QoQ: -46.76% | YoY: 928.13%
Operating Income
Increasing
20.50M
QoQ: -54.55% | YoY: 293.40%
Net Income
Increasing
27.20M
QoQ: -49.35% | YoY: 545.90%
EPS
Increasing
1.60
QoQ: -50.16% | YoY: 521.05%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2025 73.10 1.60 +67.3% View
Q4 2024 151.60 3.20 +46.3% View
Q3 2024 57.70 -0.30 +12.5% View
Q2 2024 189.00 1.89 +92.1% View
Q1 2024 43.70 -0.38 -34.7% View